Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid

Add time:09/10/2019    Source:sciencedirect.com

Valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid, were found to inhibit strongly the metabolism of decanoic acid in homogenates of rat liver. Reductions in decanoate consumption in response to inhibitors were paralleled by decreases in the formation of octanoic and hexanoic acids, two products of decanoate β-oxidation. In contrast, 4-pentenoic acid, an established inhibitor of long-chain fatty acid β-oxidation, had little effect on the metabolism of decanoate. It is concluded that the title compounds are potent, broad-spectrum inhibitors of fatty acid β-oxidation, a property which may be of key toxicological importance in the pathology of valproate-induced liver injury.

We also recommend Trading Suppliers and Manufacturers of 4-propyl-4-pentenoic acid (cas 13722-70-8). Pls Click Website Link as below: cas 13722-70-8 suppliers

Prev:Derivatization oriented strategy for enhanced detection of valproic acid and its metabolites in human plasma and detection of valproic acid induced reactive oxygen species associated protein modifications by mass spectrometry
Next:Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy)